JP2008531655A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531655A5
JP2008531655A5 JP2007557507A JP2007557507A JP2008531655A5 JP 2008531655 A5 JP2008531655 A5 JP 2008531655A5 JP 2007557507 A JP2007557507 A JP 2007557507A JP 2007557507 A JP2007557507 A JP 2007557507A JP 2008531655 A5 JP2008531655 A5 JP 2008531655A5
Authority
JP
Japan
Prior art keywords
methoxy
ethoxy
hexahydrophenanthridine
pyrimidin
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007557507A
Other languages
English (en)
Japanese (ja)
Other versions
JP5478828B2 (ja
JP2008531655A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/060377 external-priority patent/WO2006092422A1/en
Publication of JP2008531655A publication Critical patent/JP2008531655A/ja
Publication of JP2008531655A5 publication Critical patent/JP2008531655A5/ja
Application granted granted Critical
Publication of JP5478828B2 publication Critical patent/JP5478828B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007557507A 2005-03-02 2006-03-01 6−ヘテロシクリル置換されたヘキサヒドロフェナントリジン誘導体の新規の塩 Expired - Fee Related JP5478828B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05101619 2005-03-02
EP05101619.4 2005-03-02
EP05108442 2005-09-14
EP05108442.4 2005-09-14
PCT/EP2006/060377 WO2006092422A1 (en) 2005-03-02 2006-03-01 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013241863A Division JP2014040482A (ja) 2005-03-02 2013-11-22 6−ヘテロシクリル置換されたヘキサヒドロフェナントリジン誘導体の新規の塩

Publications (3)

Publication Number Publication Date
JP2008531655A JP2008531655A (ja) 2008-08-14
JP2008531655A5 true JP2008531655A5 (https=) 2009-04-16
JP5478828B2 JP5478828B2 (ja) 2014-04-23

Family

ID=36295528

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007557507A Expired - Fee Related JP5478828B2 (ja) 2005-03-02 2006-03-01 6−ヘテロシクリル置換されたヘキサヒドロフェナントリジン誘導体の新規の塩
JP2013241863A Pending JP2014040482A (ja) 2005-03-02 2013-11-22 6−ヘテロシクリル置換されたヘキサヒドロフェナントリジン誘導体の新規の塩

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013241863A Pending JP2014040482A (ja) 2005-03-02 2013-11-22 6−ヘテロシクリル置換されたヘキサヒドロフェナントリジン誘導体の新規の塩

Country Status (24)

Country Link
US (4) US7718668B2 (https=)
EP (3) EP2189454B1 (https=)
JP (2) JP5478828B2 (https=)
KR (2) KR101352687B1 (https=)
AT (1) ATE450524T1 (https=)
AU (1) AU2006219867B2 (https=)
BR (1) BRPI0607645A2 (https=)
CA (1) CA2598860C (https=)
CY (1) CY1109753T1 (https=)
DE (1) DE602006010824D1 (https=)
DK (1) DK1856093T3 (https=)
EA (1) EA015376B1 (https=)
ES (2) ES2440590T3 (https=)
HR (1) HRP20100086T1 (https=)
IL (2) IL185276A (https=)
ME (1) ME01172B (https=)
MX (1) MX2007010400A (https=)
NO (1) NO339416B1 (https=)
NZ (2) NZ589278A (https=)
PL (1) PL1856093T3 (https=)
PT (1) PT1856093E (https=)
RS (1) RS51345B (https=)
SI (1) SI1856093T1 (https=)
WO (1) WO2006092422A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE353217T1 (de) 2002-08-29 2007-02-15 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
CA2556086C (en) 2004-02-18 2014-04-01 Altana Pharma Ag Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors
PL2589599T4 (pl) 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
EP1725534A1 (en) * 2004-03-10 2006-11-29 Altana Pharma AG Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
PL1856093T3 (pl) 2005-03-02 2010-05-31 Takeda Gmbh Chlorowodorek (2R,4aR,10bR)-6-(2,6-dimetoksy-pirydyn-3-ylo)-9-etoksy-8-metoksy-1,2,3,4,4a,10b-heksahydrofenantrydyn-2-olu
WO2008028914A1 (en) 2006-09-07 2008-03-13 Nycomed Gmbh Combination treatment for diabetes mellitus
WO2009109525A1 (en) * 2008-03-03 2009-09-11 Nycomed Gmbh Use of a specific pde4 inhibitor for the treatment and/or prophylaxis of non-alcoholic fatty liver disease
MX375348B (es) 2011-12-15 2025-03-06 Alkermes Pharma Ireland Ltd Composiciones de la buprenorfina y antagonistas de los receptores opioide-mu.
WO2015110394A1 (en) 2014-01-22 2015-07-30 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
WO2018037109A1 (en) 2016-08-26 2018-03-01 Takeda Gmbh Treatment of nonalcoholic fatty liver disease
JP2020510071A (ja) 2017-03-16 2020-04-02 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング 特発性肺線維症の治療

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027055D0 (en) 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
AU650953B2 (en) * 1991-03-21 1994-07-07 Novartis Ag Inhaler
BR9707233A (pt) 1996-01-31 1999-07-20 Byk Gulden Lomberg Chem Fab Fenantridinas
SI0889886T1 (en) 1996-03-26 2003-02-28 Altana Pharma Ag Novel phenanthridines substituted in the 6 position
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
PL189641B1 (pl) 1996-11-11 2005-09-30 Altana Pharma Ag Benzonaftyrydyny, środki farmaceutyczne je zawierające oraz zastosowanie benzonaftyrydyn
SI0968211T1 (en) 1997-03-07 2004-02-29 Altana Pharma Ag Tetrazole derivatives
ES2193539T3 (es) 1997-06-03 2003-11-01 Altana Pharma Ag Benzonaftiridinas.
WO1999005112A1 (en) 1997-07-25 1999-02-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted 6-alkylphenanthridines
JP2001510827A (ja) 1997-07-25 2001-08-07 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 置換6−フェニルフェナントリジン
PT998460E (pt) 1997-07-25 2004-07-30 Altana Pharma Ag Novos derivados de tetrazole
DK1075477T3 (da) 1998-05-05 2003-06-30 Altana Pharma Ag Nye benzonaphthyridin-N-oxider
AU5970199A (en) 1998-08-31 2000-03-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
TR200501553T2 (tr) 1999-01-15 2005-06-21 Altana Pharma Ag PDE-IV inhibe edici aktivitesi olan fenilfenantridinler
WO2000042019A1 (en) 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh 6-arylphenanthridines with pde-iv inhibiting activity
DE60020079T2 (de) 1999-01-15 2006-01-19 Altana Pharma Ag Phenanthridin-N-oxide mit PDE-IV-hemmender Wirkung
ES2241571T3 (es) 1999-01-15 2005-11-01 Altana Pharma Ag N-oxidos de fenantrinida con actividad inhividora de pde-iv.
CA2360386A1 (en) 1999-01-15 2000-07-20 Beate Gutterer Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
WO2001051470A1 (en) 2000-01-11 2001-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides
DE60125026T2 (de) 2000-03-23 2007-06-28 Takeda Pharmaceutical Co. Ltd. Fluorisochinolinderivate, verfahren zu ihrer herstellung und ihre anwendung
ES2236288T3 (es) 2000-07-14 2005-07-16 Altana Pharma Ag 6-heteroarilfenantridinas.
WO2002005616A1 (en) * 2000-07-14 2002-01-24 Altana Pharma Ag Novel 6-phenylphenanthridines
WO2002006238A1 (en) 2000-07-14 2002-01-24 Altana Pharma Ag Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
US6936622B2 (en) 2001-02-21 2005-08-30 Altana Pharma Ag 6-phenylbenzonaphthyridines
CA2495597A1 (en) 2002-08-17 2004-03-04 Altana Pharma Ag Novel phenanthridines
RS20050117A (sr) 2002-08-17 2007-06-04 Altana Pharma Ag., Novi benzonaftiridini
ATE353217T1 (de) 2002-08-29 2007-02-15 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
JP4587294B2 (ja) 2002-08-29 2010-11-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Pde4インヒビターとしての2−ヒドロキシ−6−フェニルフェナントリジン
CA2556086C (en) 2004-02-18 2014-04-01 Altana Pharma Ag Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors
AR049419A1 (es) 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
PL2589599T4 (pl) * 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
AU2005220034A1 (en) 2004-03-09 2005-09-15 Nycomed Gmbh Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
WO2005085203A1 (en) 2004-03-10 2005-09-15 Altana Pharma Ag Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
EP1725534A1 (en) 2004-03-10 2006-11-29 Altana Pharma AG Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
CA2558390A1 (en) 2004-03-10 2005-09-22 Altana Pharma Ag Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
PL1856093T3 (pl) 2005-03-02 2010-05-31 Takeda Gmbh Chlorowodorek (2R,4aR,10bR)-6-(2,6-dimetoksy-pirydyn-3-ylo)-9-etoksy-8-metoksy-1,2,3,4,4a,10b-heksahydrofenantrydyn-2-olu

Similar Documents

Publication Publication Date Title
US10251876B2 (en) Method for treating tumour, pharmaceutical composition and medicinal kit
JP2008531655A5 (https=)
CN102675136B (zh) 包含3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚和nsaid的药物组合物
JP2021063119A (ja) 噴霧乾燥製剤
CA2796774C (en) Pharmaceutical combination for the treatment of pain
JP2017528503A5 (https=)
JP2010502767A5 (https=)
JP2017528507A5 (https=)
JP2010515715A5 (https=)
JP2009541443A5 (https=)
JP4937760B2 (ja) 4−(4−メチルピペラジン−1−イルメチル)−n−[4−メチル−3−(4−ピリジン−3−イル)ピリミジン−2−イルアミノ)フェニル]−ベンズアミドの塩形態
FI3335707T3 (fi) Muskariinireseptoriantagonistin ja beeta2-adrenergisen reseptorin agonistin yhdistelmiä
JP2023523596A (ja) 心血管疾患および/または腎疾患を治療および/または予防するためのフィネレノンとsglt2阻害剤の組み合わせ
JP2017527605A5 (https=)
HRP20151338T1 (hr) [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoksi-etil)-4trifluorometoksi-1h-indol-3-il]metanon kao inhibitor triptaze mastocita
JP2012526766A5 (https=)
JP2023143940A5 (https=)
JP2017534654A5 (https=)
JP2013506004A5 (https=)
JP2008536853A5 (https=)
TWI751456B (zh) 癌症療法
JP2025163212A5 (https=)
US11040041B2 (en) Method of treating pulmonary arterial hypertension
JP5831449B2 (ja) ソリフェナシン含有医薬組成物
CN109843885A (zh) 抗肿瘤杂环并咪唑类化合物的药用盐